Article

Impact of COVID-19 on diagnoses, monitoring and mortality in people with type 2 diabetes: a UK-wide cohort study involving 14 million people in primary care

2020-10-27

Abstract excerpt

<h4>AIMS</h4> To compare trends in diagnoses, monitoring and mortality in patients with type 2 diabetes, before and after the first COVID-19 peak. <h4>METHODS</h4> We constructed a cohort of 25 million patients using electronic health records from 1831 UK general practices registered with the Clinical Practice Research Datalink (CPRD), including 14 million patients followed between March and December 2020. We comp...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 86a51557-c09d-5ab2-b2e3-2a88040f9802
DOI: 10.1101/2020.10.25.20200675

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Impact of COVID-19 on diagnoses, monitoring and mortality in people with type 2 diabetes: a UK-wide cohort study involving 14 million people in primary careDOI 10.1101/2020.10.25.20200675Read

Impact of COVID-19 restrictions on diabetes health checks and prescribing for people with type 2 diabetes: a UK-wide cohort study involving 618,161 people in primary careSemantic proximity Read

Type 1 and Type 2 Diabetes and COVID-19 Related Mortality in England: A Whole Population StudySemantic proximity Read

Exploring the impact of the COVID-19 pandemic on patients with type 2 diabetes and primary care utilisation: a scoping reviewSemantic proximity Read

COVID-19 Disease in People with Diabetes in Scotland: Incidence, Severity and Risk Stratification Using Matched Case-Control and Prospective Cohort StudiesSemantic proximity Read

Diabetes during the COVID-19 pandemic: are people getting access to the right level of care?Semantic proximity Read

Estimating excess 1- year mortality from COVID-19 according to underlying conditions and age in England: a rapid analysis using NHS health records in 3.8 million adultsSemantic proximity Read

Association of polypharmacy and burden of comorbidities on COVID-19 adverse outcomes in people with type 1 or type 2 diabetesSemantic proximity Read

Changes in cardiovascular disease monitoring in English primary care during the COVID-19 pandemic: an observational cohort studySemantic proximity Read

A reproducible open-source framework for defining type 1 and type 2 diabetes research cohorts in routinely collected electronic health record dataSemantic proximity Read

GLP Medications and Severe Post-COVID-19 Outcomes Among Individuals with Type 2 Diabetes MellitusSemantic proximity Read

Weight trends amongst adults with diabetes or hypertension during the COVID-19 pandemic: an observational study using OpenSAFELYSemantic proximity Read

Multi-site analysis of COVID-19 and new-onset diabetes reveals need for improved sensitivity of EHR-based COVID-19 phenotypes-a DiCAYA Network analysis.Semantic proximity Read